Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
about
Temozolomide for high grade gliomaRadiation and concomitant chemotherapy for patients with glioblastoma multiformeBevacizumab: a treatment option for recurrent glioblastoma multiforme.Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.Early toxicity predicts long-term survival in high-grade glioma.Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells.Epigenetic markers in human gliomas: prospects for therapeutic intervention.Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.Evolving strategies: future treatment of glioblastoma.Bevacizumab for the treatment of glioblastoma.Downregulation of Id2 increases chemosensitivity of glioma.Infrasound sensitizes human glioblastoma cells to cisplatin-induced apoptosis.Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases.Treatment of glioblastoma multiforme with high doses of carmustine intracavitary, in an infant.
P2860
Q24197645-6D95E6D2-4DFC-46DE-A05E-B6F514E2B2F4Q26827957-774E53F9-79E6-4DD7-8972-5B6680DC491AQ33365902-943BD018-9FD5-4D21-8507-70DBAB738594Q34048935-EEDFB15A-3D90-4857-8EC2-B154A14444EFQ35006910-D10ACED9-2D0B-4DAF-BCA5-010061B28B8BQ35973580-3955CA81-6585-40D3-8348-D77D2D50D0B9Q37301207-E66DFC50-A9CA-4026-B14B-9794638F8D0CQ37798254-189365DE-2219-4472-89D8-06E2A4BF6B30Q37846215-68D2DE97-A8E5-4615-B529-4D14A63402B8Q37862235-5F8875F5-2400-4706-8E54-71D06C1957CFQ38129428-02808578-F277-424C-AE68-4BE75DA264F8Q38899685-EE8C71D8-6BEA-43AC-B32D-7D88F5F8455DQ39242211-17DD99C6-DF9E-4DB8-BD31-9AF1C26181E0Q42317473-74C98F28-862D-4CD4-A67F-327ED11ABA64Q43964349-1F5FF36C-11C9-416E-8704-02A4745D6DD3Q48743197-F4AE9B6A-0AF7-4EFB-94AE-FC2F32BC3943
P2860
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@ast
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@en
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@nl
type
label
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@ast
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@en
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@nl
prefLabel
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@ast
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@en
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@nl
P2093
P1433
P1476
Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.
@en
P2093
Brennan M R Spiegel
Eric Esrailian
Loren Laine
Marc C Chamberlain
P2860
P304
P356
10.2165/00023210-200721090-00006
P577
2007-01-01T00:00:00Z
P5875
P6179
1004321600